Servicio de Endocrinología y Nutrición. Complexo Hospitalario Universitario de A Coruña.
Nutr Hosp. 2020 Dec 16;37(6):1197-1200. doi: 10.20960/nh.03233.
Introduction: the objective was to assess the utility of the Eating Assessment Tool (EAT-10) in hospitalisation units with patients at high risk of dysphagia. Patients and methods: a cross-sectional study was conducted in the Neurology and Internal Medicine wards; patients with admission < 24 hours and in a terminal stage of disease were excluded. In the first 24-48 hours of admission the presence of dysphagia as assessed with the EAT-10, the risk of malnutrition as assessed with the Malnutrition Universal Screening Tools (MUST), and comorbidities using the Charlson index were screened. Results: a total of 169 patients were recruited (76.0 years, 52 % women); 19.5 % were at risk of malnutrition. The EAT-10 instrument could be administered in 80.6 % of the patients, and was positive in 26.6 % (women 34.1 % vs. men 18.4 %; p = 0.025). When comparing patients with higher comorbidity with those with a lower Charlson index, a lower response rate to EAT-10 was observed (78.4 % vs. 93.9 %; p = 0.038), without differences in screening positivity (28.3 % vs. 19.4 %; p = 0.310). The prevalence of dysphagia risk was higher in the Internal Medicine unit than in the Neurology unit (30.4 % vs. 19.6 %; p = 0.133), as was the percentage of cases in which screening could not be performed (21.1 % vs. 11.1 %; p = 0.011). There were no significant differences in risk of malnutrition, mortality, hospital stay, or readmission according to the EAT-10. Conclusions: The EAT-10 has limited utility in the studied hospitalisation units due to a high rate of unfeasible tests, especially among patients at higher risk of dysphagia.
本研究旨在评估进食评估工具(EAT-10)在高吞咽风险住院患者中的应用价值。
在神经内科和内科病房进行了一项横断面研究;排除入院不足 24 小时和疾病终末期的患者。在入院的头 24-48 小时内,使用 EAT-10 评估吞咽困难的情况,使用营养不良通用筛查工具(MUST)评估营养不良的风险,以及使用 Charlson 指数评估合并症。
共纳入 169 例患者(76.0 岁,52%为女性);19.5%存在营养不良风险。EAT-10 量表可用于 80.6%的患者,阳性率为 26.6%(女性 34.1%比男性 18.4%;p=0.025)。在比较合并症较高的患者和 Charlson 指数较低的患者时,EAT-10 的应答率较低(78.4%比 93.9%;p=0.038),但筛查阳性率无差异(28.3%比 19.4%;p=0.310)。与神经内科病房相比,内科病房的吞咽风险发生率更高(30.4%比 19.6%;p=0.133),无法进行筛查的比例也更高(21.1%比 11.1%;p=0.011)。根据 EAT-10,营养不良风险、死亡率、住院时间或再入院率无显著差异。
在研究的住院病房中,EAT-10 的应用价值有限,因为无法进行测试的比例较高,尤其是在吞咽风险较高的患者中。